Diseases, Conditions, Syndromes

Nirmatrelvir-ritonavir effective for outpatient treatment of COVID-19

For outpatient treatment of COVID-19, nirmatrelvir-ritonavir is effective for reducing 30-day hospitalization or death, while molnupiravir is associated with a reduction in 30-day mortality, according to a study published ...

page 3 from 3